Recombinant human serum albumin (OsrHSA) has emerged as an important innovation in the field of biopharmaceuticals, offering promising breakthroughs across many clinical and industrial applications. With its structural similarity to The natural way derived human serum albumin, OsrHSA supplies a safer, much more reliable alternative for therapeutic